Cinobufotalin, a cardiac toxin from toad venom, exhibits anti-hepatocellular carcinoma (HCC) activity by inducing growth arrest and apoptosis via ceramide generation in vitro. It reverses multidrug resistance by downregulating P-gp and MRP-1, and enhances the maturation and function of dendritic cells from chronic hepatitis B patients, potentially boosting antiviral immunity.